A. Wahle

发表

Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial

Travis B. Smith, Elvira N. Chegarnov, G. Fish, 2018, JAMA ophthalmology.

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

D. Drossman, J. Johanson, R. Ueno, 2008, Alimentary pharmacology & therapeutics.

Lubiprostone Significantly Improves Symptom Relief Rates in Adults With Irritable Bowel Syndrome and Constipation (IBS-C): Data from Two Twelve-Week, Randomized, Placebo-Controlled, Double-Blind Trials

W. Chey, D. Drossman, R. Ueno, 2007 .

Pooled Analysis of the Most Frequent Adverse Events Associated with the Use of Lubiprostone: 1264

R. Ueno, A. Wahle, E. Rivera, 2006 .

Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics

Lauren A. Peccoralo, R. Rosenthal, T. Wilens, 2021, JAMA network open.

SCORE STUDY REPORT 12: Development of Venous Collaterals in the Score Study

I. Scott, B. Blodi, M. Ip, 2013, Retina.

Bupropion and Naltrexone in Methamphetamine Use Disorder.

Udi E. Ghitza, A. Rush, M. Trivedi, 2021, The New England journal of medicine.

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Daniel Polsky, U. Ghitza, E. Nunes, 2014, The American journal of psychiatry.

Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.

Udi E. Ghitza, U. Ghitza, S. Sonne, 2017, Drug and alcohol dependence.

Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.

K. O’grady, J. Marsden, J. Gryczynski, 2017, Journal of substance abuse treatment.

AUTHOR ACCEPTED MANUSCRIPT FOR PUBLICATION IN JOURNAL OF SUBSTANCE ABUSE TREATMENT (25.01.17) Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST Schwartz

K. O’grady, J. Marsden, J. McNeely, 2017 .

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

K. O’grady, D. Svikis, R. Schwartz, 2016, Annals of Internal Medicine.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Udi E. Ghitza, U. Ghitza, S. Sonne, 2017, Drug and alcohol dependence.

M1706 Discontinuation of Lubiprostone Treatment for Irritable Bowel Syndrome with Constipation Is Not Associated with Symptom Increase or Recurrence: Results from a Randomized Withdrawal Study

W. Chey, R. Saad, R. Ueno, 2008 .

Evaluation of Safety and Efficacy in a Twelve-Month Study of Lubiprostone for the Treatment of Chronic Idiopathic Constipation: 1269

R. Ueno, R. Panas, A. Wahle, 2006 .

Efficacy and Safety of Lubiprostone in a Subgroup of Constipation Patients Diagnosed with Irritable Bowel Syndrome with Constipation (IBS-C): 1270

J. Johanson, R. Ueno, A. Wahle, 2006 .

Lubiprostone for the Treatment of Chronic Constipation: Patient Symptom Ratings

R. Ueno, A. Wahle, T. Joswick, 2006 .

Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

U. Ghitza, Li-Tzy Wu, Abigail G Matthews, 2021, Addiction.

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Udi E. Ghitza, E. Nunes, D. Babcock, 2014, The American journal of psychiatry.